Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease

被引:257
作者
Barabino, Stefano [2 ]
Chen, Yihe [1 ]
Chauhan, Sunil [1 ]
Dana, Reza [1 ]
机构
[1] Harvard Univ, Dept Ophthalmol, Schepens Eye Res Inst, Massachusetts Eye & Ear Infirm,Sch Med, Boston, MA 02114 USA
[2] Univ Genoa, Clin Oculist, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy
基金
美国国家卫生研究院;
关键词
Ocular surface; Dry eye disease; Autoimmunity; Inflammation; Anti-inflammatory agents; REGULATORY T-CELLS; MATRIX-METALLOPROTEINASE ACTIVITY; HORMONE REPLACEMENT THERAPY; GROWTH-FACTOR BETA-1; TOLL-LIKE RECEPTORS; LIGAND; PD-L1; SJOGRENS-SYNDROME; KERATOCONJUNCTIVITIS SICCA; CONJUNCTIVAL EPITHELIUM; CORNEAL EPITHELIUM;
D O I
10.1016/j.preteyeres.2012.02.003
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The tear film, lacrimal glands, corneal and conjunctival epithelia and Meibomian glands work together as a lacrimal functional unit (LFU) to preserve the integrity and function of the ocular surface. The integrity of this unit is necessary for the health and normal function of the eye and visual system. Nervous connections and systemic hormones are well known factors that maintain the homeostasis of the ocular surface. They control the response to internal and external stimuli. Our and others' studies show that immunological mechanisms also play a pivotal role in regulating the ocular surface environment. Our studies demonstrate how anti-inflammatory factors such as the expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in corneal cells, immature corneal resident antigen-presenting cells, and regulatory T cells play an active role in protecting the ocular surface. Dry eye disease (DED) affects millions of people worldwide and negatively influences the quality of life for patients. In its most severe forms, DED may lead to blindness. The etiology and pathogenesis of DED remain largely unclear. Nonetheless, in this review we summarize the role of the disruption of afferent and efferent immunoregulatory mechanisms that are responsible for the chronicity of the disease, its symptoms, and its clinical signs. We illustrate current anti-inflammatory treatments for DED and propose that prevention of the disruption of immunoregulatory mechanisms may represent a promising therapeutic strategy towards controlling ocular surface inflammation. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:271 / 285
页数:15
相关论文
共 179 条
[1]   Clinical cure of bacterial conjunctivitis with azithromycin 1%: Vehicle-controlled, double-masked clinical trial [J].
Abelson, Mark B. ;
Heller, Warren ;
Shapiro, Aron M. ;
Si, Erwin ;
Hsu, Peng ;
Bowman, Lyle M. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (06) :959-965
[2]   Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier [J].
Ambati, Balamurali K. ;
Patterson, Emory ;
Jani, Pooja ;
Jenkins, Crystal ;
Higgins, Eric ;
Singh, Nirbhai ;
Suthar, Tushar ;
Vira, Nehali ;
Smith, Kimberly ;
Caldwell, Ruth .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (04) :505-508
[3]   Corneal avascularity is due to soluble VEGF receptor-1 [J].
Ambati, Balamurali K. ;
Nozaki, Miho ;
Singh, Nirbhai ;
Takeda, Atsunobu ;
Jani, Pooja D. ;
Suthar, Tushar ;
Albuquerque, Romulo J. C. ;
Richter, Elizabeth ;
Sakurai, Eiji ;
Newcomb, Michael T. ;
Kleinman, Mark E. ;
Caldwell, Ruth B. ;
Lin, Qing ;
Ogura, Yuichiro ;
Orecchia, Angela ;
Samuelson, Don A. ;
Agnew, Dalen W. ;
St. Leger, Judy ;
Green, W. Richard ;
Mahasreshti, Parameshwar J. ;
Curiel, David T. ;
Kwan, Donna ;
Marsh, Helene ;
Ikeda, Sakae ;
Leiper, Lucy J. ;
Collinson, J. Martin ;
Bogdanovich, Sasha ;
Khurana, Tejvir S. ;
Shibuya, Masabumi ;
Baldwin, Megan E. ;
Ferrara, Napoleone ;
Gerber, Hans-Peter ;
De Falco, Sandro ;
Witta, Jassir ;
Baffi, Judit Z. ;
Raisler, Brian J. ;
Ambati, Jayakrishna .
NATURE, 2006, 443 (7114) :993-997
[4]   A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases [J].
Amin, AR ;
Attur, MG ;
Thakker, GD ;
Patel, PD ;
Vyas, PR ;
Patel, RN ;
Patel, IR ;
Abramson, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14014-14019
[5]   Systemic omega-6 essential fatty acid treatment and PGE1 tear content in Sjogren's syndrome patients [J].
Aragona, P ;
Bucolo, C ;
Spinella, R ;
Giuffrida, S ;
Ferreri, G .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (12) :4474-4479
[6]   The controlled-environment chamber: A new mouse model of dry eye [J].
Barabino, S ;
Shen, LL ;
Chen, L ;
Rashid, S ;
Rolando, M ;
Dana, MR .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (08) :2766-2771
[7]   Systemic linoleic and γ-linolenic acid therapy in dry eye syndrome with an inflammatory component [J].
Barabino, S ;
Rolando, M ;
Camicione, P ;
Ravera, G ;
Zanardi, S ;
Giuffrida, S ;
Calabria, G .
CORNEA, 2003, 22 (02) :97-101
[8]  
Barabino Stefano, 2007, Chem Immunol Allergy, V92, P176, DOI 10.1159/000099268
[9]   Immune response in the conjunctival epithelium of patients with dry eye [J].
Barabino, Stefano ;
Montaldo, Elisa ;
Solignani, Federico ;
Valente, Cristiana ;
Mingari, Maria Cristina ;
Rolando, Maurizio .
EXPERIMENTAL EYE RESEARCH, 2010, 91 (04) :524-529
[10]   Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface [J].
Battat, L ;
Macri, A ;
Dursun, D ;
Pflugfelder, SC .
OPHTHALMOLOGY, 2001, 108 (07) :1230-1235